TAG's comments and recommendations to the FDA Vaccines and Related Biological Products Advisory Committee, encompassing a broad range of community concerns regarding COVID-19 vaccine development and regulatory review.
Please join us at our annual, and first ever virtual, Research in Action Awards on Thursday, November 19, 2020. At this time of great turmoil and when activism to end infectious disease is more vital than ever, it’s so important to gather virtually to celebrate life, commemorate those we’ve lost, and recognize champions of progress and justice.
TAG is one of the organizations who supports confidentiality in contact tracing and is applauding the passage of this legislation. As TAG's State and Local Policy Director Annette Gaudino says in this statement, “There can be no effective contact tracing without trust.”
Two recent developments have brought renewed publicity to proposals to conduct human challenge studies to test COVID-19 vaccine candidates: an open letter from the organization 1DaySooner and media reports that Adrian Hill’s Oxford University research group is planning a challenge study, taking advantage of the lack of regulatory oversight of human challenge experiments in the United Kingdom.
Several prominent community health organizations with decades of experience in HIV/AIDS advocacy today served the New York City Board of Health with a formal petition calling for an emergency meeting to address racism and over-policing of Black and Latinx communities as concurrent, city-wide public health emergencies.
On May 15, TAG Executive Director Mark Harrington presented this testimony to the New York City Council Committee on and Health and the New York Council Committee on Hospitals on Oversight: NYC's Plan for COVID-19 Testing and Contact Tracing.